Drug details

Lantidra (donislecel-jujn allogeneic pancreatic islet cellular)

type of

The following drugs are related to Lantidra, either as a replacement or used together:

• Admelog (insulin lispro injection)
• Afrezza (insulin human inhalation powder)
• Basaglar (basaglar insulin glargine subcutaneous injection)
• Fiasp (insulin aspart injection for subcutaneous or intravenous use)
• Humalog (insulin lispro (human analog))
• Humalog 75-25 (75-25 insulin lispro suspension and 25 insulin lispro injection)
• NovoLog (insulin aspart [rdna origin] inj)
• Tresiba (insulin degludec injection)
• Lantus (insulin glargine [rdna origin] injection)
• Semglee (insulin glargine injection)
• Toujeo (insulin glargine injection for subcutaneous use)
• Toujeo U 300 (insulin glargine injection for subcutaneous use)
• Rezvoglar (insulin glargine-aglr injection)
• Lyumjev (insulin lispro-aabc injection)
• Myxredlin (insulin regular human)
• Symlin (pramlintide acetate injection)
• Tzield (teplizumab-mzwv injection, for intravenous use)